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For many years 2,3-diphosphoglycerate (DPG) has been known to be gen- 
erated in the erythrocyte by a shunt in the Embden-Myerhof pathway. Levels of 
DPG are very high in the eythrocyte compared to its concentration in other 
tissues.’ Because its function was unknown, DPG could have been characterized 
as “a substance in search of a function.” Conversely, the greatly decreased oxygen 
affinity of intact red cells as compared to purified hemoglobin was “a function in 
search of an explanation.” Now it appears that the “substance” and the “function” 
have come together. The pioneering work of Chanutin and Curnish2 and of 
Benesch and coworkers3 has shown that DPG complexes with reduced hemo- 
globin. This binding of DPG markedly decreases the oxygen affinity of the hemo- 
globin as compared with that of purified hemoglobin. 
Similarly, it has been noted that the oxyhemoglobin dissociation curve is shifted 
toward the right in various types of hypoxia such as anemia and chronic pul- 
monary disease,4-6 and altitude.’ It has been subsequently demonstrated that this 
right shift is associated with marked elevations in red cell DPG concentrations.8 
In view of the leftward (Haldane) shift of the oxyhemoglobin curve induced 
by CO, possible interactions of the right shift associated with DPG alterations con- 
stituted an appropriate subject for inquiry. This is in keeping with the best tra- 
dition associated with CO research, i.e., the manipulation of this toxic gas in order 
to gain some insights into the inner workings of that remarkable tetrapyrrole, 
hemoglobin. 
Methods 
Twelve human volunteers were given doses of CO calculated to produce 15 to 
25% COHb. Approximately three hours after the initial dose of CO, COHb levels 
were estimated by the breathholding method of Jones and colleagues? with breath 
CO concentrations determined by the use of a nondispersive, Luft-type infra-red 
spectrophotometer (Lira Model 200, MSA), which utilizes a 1-meter cell. The 
correlation of alveolar CO with COHb, the latter determined by the method of 
Collison and coworkers,l* appeared to follow the regression developed by Jones 
and coworkers.g 
Prior to exposure to CO, red cell DPG was determined by use of the chroma- 
tropic acid method of Bartlettll as modified in our laboratories.’2 This determina- 
tion was repeated six hours after the first dose of CO. Control determinations 
of DPG were made on samples obtained at the same times of day as the previous 
day’s exposure procedure, i.e., 9 a.m. and 3 p.m. 
In addition, 42 rats were exposed to approximately 0.8% CO for ten to 15 
minutes. This was sufficient to produce peak concentrations of 50-60% COHb, 
as estimated by the IL Co-oximeter. Twenty-two of this group of animals were 
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FIGURE 2. Mean A DPG following CO exposure of men (Bar 1, 3 )  and during control 
periods (Bar 2, 4 ) .  
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TABLE 1 
DPG CONCENTRATIONS N CONTROL AND CO-EXPOSED RATS 
DPG Levels Difference t-Test on 
Rats N Baseline 6 hrs (Mean k I.S.D.) Differences 
~ ~~~ 
CO-treated 22 21.3 23.5 +2.2 (k2.6) t + 3.49 
Controls 24 23.0 22.5 -0.5 (rt-2.7) p < 0.01 
dosed every hour for five hours; another group was dosed only twice, i.e., at zero 
time and at three hours. The CO-treated rats and an equal number of control 
rats were sampled for DPG at the beginning of, and at the end of, the sixth hour 
of the experiment. FIGURE 1 demonstrates the two different regimens and the 
mean levels of COHb achieved among the experimental animals and men. 
Results 
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FIGURE 4. Distribution of free and total DPG in the erythrocyte in normal, common 
hypoxias, and CO loadings. 
ficantly in CO-treated rats as compared with controls. This finding applied only 
to the rats given the two doses of CO three hours apart, rather than those exposed 
at the six hourly intervals (TABLE 1 ). (A  preliminary report has been p~blished.'~) 
Among the 12 human volunteers we found that while the control levels of 
DPG were constant or even tended to fall in the course of the day, upon exposure 
to CO there was a significant rise in DPG (FIGURE 2),  as compared to change 
in DPG on nonexposure days. However, after exposing four more subjects to 
somewhat larger doses of CO, we found that among the 16 subjects the increase 
in DPG was not significant (FIGURE 2).  
This latter finding led us to scrutinize the human data more closely. Upon 
plotting the change in DPG (i.e., change in DPG during CO exposure minus the 
change seen over the six-hour control period) against the peak COHb level pro- 
duced in our subjects, the cause and significance of the difference in response 
between the two groups of subjects became apparent. After examining those 
subjects displaying an increase in DPG, it was clear that the peak level of COHb 
(FIGURE 3) was considerably lower than COHb levels in the second group of 
subjects. Apparently the change in DPG levels is inversely related to peak COHb 
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concentrations ( r  = -0.48, p, < 0.05). This is consistent with our findings in 
rats; i.e., significant elevations in DPG accompanied only the lower CO dose 
regimens (TABLE 1 ) .  
Discussion 
It is now known that reduced (deoxy) hemoglobin has a much higher binding 
affinity for DPG than either oxy- or carbo~yhemoglobin.~~ The latter two forms 
of hemoglobin have approximately equal affinities for DPG. The increased affinity 
of deoxyhemoglobin for DPG has suggested one mechanism for regulation of 
DPG level~.~J5 In normal venous blood about 25-30% of the hemoglobin is in 
the reduced form. Much of the DPG may be bound to reduced hemoglobin in 
the venous blood, while most of the remainder of the DPG is free within the 
cell (the column on the right in (FIGURE 4) is total DPG and indicates what is 
assayed). In common hypoxias we find an increased proportion of reduced versus 
oxygenated hemoglobin (the darkened portions of bar graphs in FIGURE 4 ) .  With 
this increased reduced hemoglobin we have an increase in potential DPG- 
binding sites and thus an increased amount of DPG bound to reduced hemoglobin. 
Those mechanisms controlling DPG concentrations in the red cell would pre- 
sumably respond only to changes in free DPG levels. As more of the free DPG 
becomes bound, there is a drop in free DPG within the erythrocyte. Thus, DPG 
synthesis may be activated so as to maintain free DPG at its original level. Ac- 
cordingly, the increase in the bound DPG means a net increase in the total DPG. 
This hemoglobin-binding mechanism is probably a factor in the elevation of DPG 
in the common hypoxias. 
However, we often see increases in DPG in anemias8 that are greater than this 
mechanism alone could account for. In an attempt to locate a possible second 
mechanism, we have sought to produce a type of hypoxia that does not increase 
the number of available binding sites. Carboxyhemoglobin has the same low 
affinity for DPG as oxyhemoglobin. Thus when we load an organism with CO, 
we produce hypoxia by binding a portion of hemoglobin so that it will no longer 
transport oxygen; secondly, we also produce the Haldane (leftward) shift of the 
02 dissociation curve; thirdly, we also decrease the amount of hemoglobin avail- 
able for binding DPG (the sum of this potential decrease is represented by the 
clear areas of the third row of bar graphs in FIGURE 4 ) .  Hence, the DPG bound 
to hemoglobin should be either normal or decreased. The amount of free (un- 
bound) DPG should remain unchanged. Therefore, considering only the hemo- 
globin-binding mechanism, if CO hypoxia produces any change, it should cause 
a somewhat reduced amount of total DPG. There would be no way to account for 
our observed increases in total DPG. On the other hand, if some other type of 
reaction is triggered by hypoxia to raise the free DPG levels, we might find an 
increase in the amount of total DPG. The finding that-at least at the lower levels 
of carboxyhemoglobin-induced hypoxia-we see an increase in DPG suggests a 
second regulatory device, i.e., hypoxia-driven enhancement of DPG synthesis, 
which is not dependent upon an increase in reduced hemoglobin. Thus the two 
mechanisms controlling DPG concentrations are simultaneously acting in differ- 
ent directions. It would appear that, of the two drives governing DPG concentra- 
tions, at higher COHb levels the decrease in available binding sites suppresses 
the DPG increase more potently than the hypoxia mechanism drives DPG 
synthesis. 
It is clear that a third variable, i.e., the pH of the blood, affects DPG levels. A 
decrease in pH results in a decrease in DPG concentrations. However, we do 
not believe that in the studies presented here that pH changes are an important 
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factor. Astrup’s previous work clearly demonstrates that with CO loadings 
averaging 15% “. . . insignificant and nonsystematic changes in blood acid-base 
occurred.”*6 Further, in our studies with rats the animals most likely to have 
a respiratory alkalosis were those receiving the higher doses of CO, and these 
were the rats that did not show a significant increase in DPG. 
These findings tend to emphasize once more the complex “fine tuning” mecha- 
nisms that modulate biological systems. These mechanisms are suggested by the 
action of the control systems that are operative in carboxyhemoglobin’s affect 
upon DPG. Not only must the hemoglobin binding and hypoxia mechanisms be 
qualitatively considered, but also their relative influence must be evaluated in any 
attempt to understand the role of DPG in modulating the erythrocyte’s gas trans- 
port function. 
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